GenSight Biologics

Paris-based GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy based treatments of retinal degenerative diseases. Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to (i) prevent retinal degeneration in selected pathological conditions and (ii) to restore vision in patients suffering from very low vision or blindness.
Company Growth (employees)
Paris, FR
Size (employees)
27 (est)+4%
GenSight Biologics was founded in 2011 and is headquartered in Paris, FR

GenSight Biologics Office Locations

GenSight Biologics has office in Paris
Paris, FR

GenSight Biologics Metrics

GenSight Biologics Summary

Founding Date


Total Funding

$77.7 m

Latest funding size

$36 m

Time since last funding

over 1 year


We estimate that GenSight Biologics's latest funding round in July 2015 was $36 m. In total, GenSight Biologics has raised $77.7 m
We estimate that GenSight Biologics's current employees are approximately 22% female and 78% male.

GenSight Biologics News

GenSight Biologics Company Life

You may also be interested in